Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NFIL3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | DPF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | FHOD3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ARFGEF3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | JSRP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | SYK | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | NOP10 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | AGO3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ARHGAP19-SLIT1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | JPH1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |